eli lilly glp-1 news is now pharma's top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating Retatrutide, the next generation of

Efficacy of TIL therapy in advanced cutaneous melanoma in the current immuno-oncology era: updated systematic review and meta-analysis

Adding 3ml creates a concentration of approximately 3.33mg/ml

There was no difference between arms in weight at 6 months (BW:2.0 kg, 4.2, 8.1, p = 0.50), however, at 12 months weight was significantly higher in the liraglutide arm (BW:8.2 kg, 1.6, 14.9, p = 0.02)

In the first study, which lasted 28 days, CJC-1295 or placebo was administered in one of four ascending single doses

Chris Masterjohn wrote an excellent review of this study and proposes other interesting possibilities, including gender differences and vitamin deficiency issues